Atlas Trials

The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach

Clinical trial NCT02363517 · UNKNOWN

Trial details

NCT number
NCT02363517
Sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis CDrug Abuse, Intravenous
Start date
2015-02-01
Primary completion
2018-12-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.